Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors
1997

Differentiating Small-Cell and Non-Small-Cell Lung Cancer Using Tumor Markers

Sample size: 261 publication Evidence: high

Author Information

Author(s): G Paone, G De Angelis, L Portalone, S Greco, S Giosue, A Taglienti, A Bisetti, F Ameglio

Primary Institution: La Sapienza University, Rome

Hypothesis

Can a mathematical score based on tumor markers effectively distinguish between small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) in a larger patient group?

Conclusion

The study confirmed that the mathematical score can correctly classify 93% of lung cancer patients into SCLC and NSCLC categories.

Supporting Evidence

  • The score correctly classified 93% of patients in the study.
  • Misclassifications were primarily in patients with low NSE levels in SCLC and high NSE levels in advanced NSCLC.
  • The study analyzed a larger group of patients compared to previous research.

Takeaway

Doctors can use a special score based on blood tests to tell if a lung cancer patient has small-cell or non-small-cell cancer, and it works really well most of the time.

Methodology

The study analyzed serum samples from 261 lung cancer patients using discriminant analysis to classify them based on tumor markers NSE and CYFRA-21.1.

Limitations

The study noted that the method may lack sensitivity in early-stage lung cancer.

Participant Demographics

The study included 261 patients, with 209 having NSCLC (151 men, 58 women) and 52 having SCLC (32 men, 20 women), median age 64 years.

Statistical Information

P-Value

p<0.00001

Statistical Significance

p<0.00001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication